ArticleJournal of gynecologic oncology2026
Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.
Article in Journal of gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTrousseau's syndrome lacks standardized diagnostic criteria, and its rarity has hindered large-scale investigations. This study aims to elucidate the diagnostic landscape of Trousseau's syndrome in gynecological malignancies within a multicenter framework and to identify prognostic determinants.
methodsA retrospective multicenter study was conducted, encompassing patients diagnosed with Trousseau's syndrome secondary to gynecologic malignancies across 6 Japanese institutions affiliated with the Tohoku Gynecologic Cancer Unit from 2003 to 2018. Institutional diagnostic criteria were consolidated, and clinical characteristics, treatment approaches, and prognostic factors were systematically analyzed.
resultsA total of 88 patients were included, the majority presenting with multiple infarctions involving cerebral infarction and hypercoagulability. However, some cases were diagnosed based on isolated cerebral infarction, highlighting variability in diagnostic criteria. Prognostic factors significantly associated with survival included D-dimer levels (p=0.030), treatment of the primary malignancy after infarction (p<0.001), International Federation of Gynecology and Obstetrics stage (p<0.001), performance status (p=0.006), and the timing of Trousseau's syndrome onset (p<0.001) in univariate analysis. Multivariate analysis revealed that treatment of the primary malignancy after infarction was a key determinant of improved prognosis.
conclusionThis study underscores the heterogeneity in diagnostic criteria for Trousseau's syndrome and suggests that hypercoagulability serves not only as a diagnostic adjunct but also as a prognostic indicator. Moreover, intervention targeting the primary malignancy after infarction significantly enhances survival outcomes, emphasizing the necessity of an integrated therapeutic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.